On value frameworks and opportunity costs in health technology assessment

被引:5
|
作者
Booth, Neill [1 ]
机构
[1] Tampere Univ, Fac Social Sci, Tampere, Finland
关键词
Costs and cost analyses; Priorities; Health; Technology assessment; ECONOMIC-EVALUATION; BENEFIT-ANALYSIS; DECISION-MAKING; EFFECTIVENESS THRESHOLDS; CARE; LIFE; US;
D O I
10.1017/S0266462319000643
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives. Proceeding from a basic concept underpinning economic evaluation, opportunity cost, this study aims to explain how different approaches to economics diverge quite dramatically in their ideas of what constitutes appropriate valuation, both in principle and practice. Because the concept of opportunity cost does not inherently specify how valuation should be undertaken or specify how appropriate any economic value framework (EVF) might be, the three main economics-based approaches to providing evidence about value for health technology assessment are described. Methods. This paper describes how the three main EVFs-namely, the extra-welfarist, welfarist, and classical-are most typically understood, applied, and promoted. It then provides clarification and assessment of related concepts and terminology. Results. Although EVFs differ, certain underlying characteristics of valuation were identified as fundamental to all approaches to economic evaluation in practice. The study also suggests that some of the rhetoric and terms employed in relation to the extra-welfarist approach are not wholly justified and, further, that only the welfarist approach ensures adherence to welfare-economic principles. Finally, deliberative analysis, especially when connected with a classical economic approach, can serve as a useful supplement to other analytical approaches. Conclusions. All three approaches to economic evaluation have something to offer assessment processes, but they all display limitations too. Therefore, the author concludes that the language of economic evaluation should be used with sufficient humility to prevent overselling of EVFs, especially with regard to the qualities of evidence they provide for priority setting processes.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 50 条
  • [1] Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further Research
    Ochalek, Jessica
    Lomas, James
    [J]. CLINICAL THERAPEUTICS, 2020, 42 (01) : 44 - 59
  • [2] HEALTH DISPARITIES IN HEALTH TECHNOLOGY ASSESSMENT: AN OPPORTUNITY FOR IMPROVEMENT
    Penley, B.
    Cook, S.
    Tan, R.
    Sarnes, E.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S515 - S515
  • [3] Value frameworks and health technology assessment: transparency in use of peer-reviewed publications
    Desai, Bansri
    Mattingly, T. Joseph
    van den Broek, Remon
    Perfetto, Eleanor M.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 : 28 - 28
  • [4] DIGITAL HEALTH VALUE ASSESSMENT FRAMEWORKS: AN INTERNATIONAL LANDSCAPE
    Jager, M. H.
    Anisha, F. H.
    McNally, B.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S251 - S251
  • [5] Health technology assessment frameworks for eHealth: A systematic review
    Vis, Christiaan
    Buhrmann, Leah
    Riper, Heleen
    Ossebaard, Hans C.
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (03) : 204 - 216
  • [6] Biodiversity assessment and opportunity costs
    Faith, DP
    [J]. INVESTING IN BIOLOGICAL DIVERSITY: THE CAIRNS CONFERENCE, 1997, : 87 - 103
  • [7] Appraisal of cancer drugs: a comparison of the French health technology assessment with value frameworks of two oncology societies
    Li, J.
    Vivot, A.
    Alter, L.
    Durand-Zaleski, I.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (04) : 405 - 409
  • [8] DOES THE TREND TOWARDS VALUE FRAMEWORKS REQUIRE NEW APPROACHES TO EVIDENCE DEVELOPMENT AND HEALTH TECHNOLOGY ASSESSMENT?
    Teale, C. W.
    Entwistle, J.
    Freeman, S.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A763 - A763
  • [9] ISPOR's Initiative on US Value Assessment Frameworks: A Missed Opportunity for ISPOR and Patients
    Perfetto, Eleanor M.
    [J]. VALUE IN HEALTH, 2018, 21 (02) : 169 - 170
  • [10] What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks
    Zhang, Mengmeng
    Bao, Yun
    Lang, Yitian
    Fu, Shihui
    Kimber, Melissa
    Levine, Mitchell
    Xie, Feng
    [J]. VALUE IN HEALTH, 2022, 25 (02) : 302 - 317